Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The Food and Drug Administration identified numerous issues with Pfizer's drug manufacturing plant in McPherson, Kan., reports Reuters.
President Donald Trump urged the Food and Drug Administration to accelerate its drug approval process during his Tuesday night address to a joint session of Congress, reports STAT.
Insurers pay more than twice the amount for orthopedic implants than hospitals do, according to a study published in the Journal of the American Medical Association.
Ridgewood, N.J.-based Valley Health System expanded its relationship with Excelerate, a strategic health sourcing company that relies on evidence-based clinical outcomes to select medical products.
Wal-Marts on Tuesday shared plans to update its mobile app and streamline pharmacy processes for customers, reports Market Watch.
Household appliances that generate electric and magnetic fields may cause pacemakers to malfunction, according to a study published Monday in Circulation.
The Food and Drug Administration approved a record-high amount of generic drugs last year.
New Brunswick, N.J.-based Johnson & Johnson on Monday released a report detailing price increases for its prescription drugs, reports CNBC.
The Food and Drug Administration approved Nesher Pharmaceuticals' oseltamivir phosphate capsules, reports Business Standard.
Boston Children's Hospital will serve as one of 24 test sites in the U.S. for a Phase 3 clinical trial of Santhera Pharmaceuticals' experimental drug for Duchenne muscular dystrophy, reports The Boston Globe.